↓ Skip to main content

Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
82 Mendeley